NeuroOne Medical Technologies
NMTC
18 hedge funds and large institutions have $3.42M invested in NeuroOne Medical Technologies in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.16% less ownership
Funds ownership: 1.99% → 1.83% (-0.16%)
10% less funds holding
Funds holding: 20 → 18 (-2)
24% less capital invested
Capital invested by funds: $4.52M → $3.42M (-$1.11M)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$14.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.35K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.13K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAAG
Wealth Alliance Advisory Group
Wichita,
Kansas
|
-$30.8K |
| 2 |
VF
Virtu Financial
New York
|
-$29K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$19.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.24K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$1.51K |
NMTC Hedge Fund Activity: Q1 2024 in Review
18 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q1 2024, worth a combined $3.42M — down 24% from $4.52M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NMTC and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $31.3K. The largest seller was Wealth Alliance Advisory Group, exiting entirely with an estimated $30.8K sold.
- 18 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q1 2024, down from 20 in Q4 2023.
- Funds reported $3.42M of NeuroOne Medical Technologies stock for Q1 2024, down 24% quarter-over-quarter.
- 1 fund opened new NeuroOne Medical Technologies positions in Q1 2024 and 3 closed out, a net change of -2 holders.
- The largest NeuroOne Medical Technologies buyer in Q1 2024 was Geode Capital Management, an estimated $31.3K added.
- The largest NeuroOne Medical Technologies seller in Q1 2024 was Wealth Alliance Advisory Group, an estimated $30.8K sold.
Based on aggregated 13F filings for Q1 2024.